Demonstrated in vivo effect

Industry

CPC
C12N2710/24171

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C12Biochemistry C12NMICRO-ORGANISMS OR ENZYMES COMPOSITIONS THEREOF PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS MUTATION OR GENETIC ENGINEERING CULTURE MEDIA C12N2710/00dsDNA Viruses

Current Industry

C12N2710/24171Demonstrated in vivo effect

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and...
- Patent number 11,732,017
- Issue date Aug 22, 2023
- The USA, as represented by the Secretary, Dept. of Health and Human Services
- Jeffrey Schlom
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Recombinant modified vaccinia virus ankara (MVA) equine encephaliti...
- Patent number 11,571,471
- Issue date Feb 7, 2023
- Bavarian Nordic A/S
- Robin Steigerwald
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immuno-oncolytic therapies
- Patent number 11,478,518
- Issue date Oct 25, 2022
- University of Pittsburgh of the Commonwealth System of Higher Education
- Stephen Howard Thorne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified interleukin 12 and use thereof in preparing drugs for trea...
- Patent number 11,345,732
- Issue date May 31, 2022
- Beijing Bio-Targeting Therapeutics Technology Inc.
- Yaohe Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified interleukin 12 and use thereof in preparing drugs for trea...
- Patent number 11,306,129
- Issue date Apr 19, 2022
- Beijing Bio-Targeting Therapeutics Technology Inc.
- Yaohe Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of MVA or MVAΔE3L as immunotherapeutic agents against solid tumors
- Patent number 11,253,560
- Issue date Feb 22, 2022
- Memorial Sloan Kettering Cancer Center
- Liang Deng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immune modulation
- Patent number 11,173,206
- Issue date Nov 16, 2021
- SEMENTIS LIMITED
- Paul Michael Howley
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and...
- Patent number 11,155,588
- Issue date Oct 26, 2021
- The USA, as represented by the Secretary, Dept. of Health and Human Services
- Jeffrey Schlom
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Recombinant modified vaccinia virus ankara (MVA) respiratory syncyt...
- Patent number 10,946,089
- Issue date Mar 16, 2021
- Bavarian Nordic A/S
- Cédric Cheminay
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Virus-based expression vectors and uses thereof
- Patent number 10,894,966
- Issue date Jan 19, 2021
- The United States of America, as represented by the Secretary, Department of...
- Bernard Moss
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Genetically engineered vaccinia viruses
- Patent number 10,888,594
- Issue date Jan 12, 2021
- National University Corporation Tottori University
- Shinsuke Nakao
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Recombinant modified vaccinia virus Ankara (MVA) equine encephaliti...
- Patent number 10,881,725
- Issue date Jan 5, 2021
- Bavarian Nordic A/S
- Robin Steigerwald
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Genetically engineered vaccinia viruses
- Patent number 10,849,946
- Issue date Dec 1, 2020
- National University Corporation Tottori University
- Shinsuke Nakao
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of MVA or MVAΔE3L as immunotherapeutic agents against solid tumors
- Patent number 10,548,930
- Issue date Feb 4, 2020
- Memorial Sloan Kettering Cancer Center
- Liang Deng
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Recombinant modified vaccinia virus ankara (MVA) respiratory syncyt...
- Patent number 10,532,094
- Issue date Jan 14, 2020
- Bavarian Nordic A/S
- Cédric Cheminay
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods for viral embolization
- Patent number 10,517,910
- Issue date Dec 31, 2019
- SILLAJEN, INC.
- Tae Ho Hwang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Nucleic acids encoding HLA-A24 agonist epitopes of MUC1-C oncoprotein
- Patent number 10,508,141
- Issue date Dec 17, 2019
- The USA, as represented by the Secretary, Dept. of Health and Human Services
- Jeffrey Schlom
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Whole expressed cell as antigen carrier, and use thereof in prepari...
- Patent number 10,138,494
- Issue date Nov 27, 2018
- FORMOSA BIOMEDICAL INC.
- Shun-Wen Ko
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Recombinant modified vaccinia virus Ankara (MVA) Respiratory Syncyt...
- Patent number 10,124,058
- Issue date Nov 13, 2018
- Bavarian Nordic A/S
- Cédric Cheminay
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and...
- Patent number 10,035,832
- Issue date Jul 31, 2018
- The United States of America, as represented by the Secretary, Department of...
- Jeffrey Schlom
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Composition and uses thereof
- Patent number 9,821,046
- Issue date Nov 21, 2017
- Oxford University Innovation Limited
- Katharine Alice Collins
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Mitogen-activated protein kinase-dependent recombinant vaccinia vir...
- Patent number 9,809,803
- Issue date Nov 7, 2017
- National University Corporation Tottori University
- Takafumi Nakamura
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Recombinant modified vaccinia virus ankara (MVA) respiratory syncyt...
- Patent number 9,717,787
- Issue date Aug 1, 2017
- Bavarian Nordic A/S
- Cédric Cheminay
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment and prevention of malaria
- Patent number 9,603,916
- Issue date Mar 28, 2017
- Oxford University Innovation Limited
- Alexander Douglas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Composition comprising a colloidal synthetic bioresorbable vector a...
- Patent number 9,433,674
- Issue date Sep 6, 2016
- Centre Nationale de Recherche Scientifique
- Yasemin Ataman-Onal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
System for treating and preventing breast cancer
- Patent number 8,933,041
- Issue date Jan 13, 2015
- The United States of America, as represented by the Secretary, Department of...
- Dennis L. Panicali
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
MVA expressing modified HIV envelope, gag, and pol genes
- Patent number 8,916,172
- Issue date Dec 23, 2014
- Emory University
- Bernard Moss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Custom vectors for treating and preventing pancreatic cancer
- Patent number 8,901,093
- Issue date Dec 2, 2014
- The United States of America, as represented by the Secretary of the Departme...
- Dennis L. Panicali
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modulation of immune responses by the poxviral K4 protein
- Patent number 8,883,168
- Issue date Nov 11, 2014
- Bavarian Nordic A/S
- Jürgen Hausmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
MVA expressing modified HIV envelope, gag, and pol genes
- Patent number 7,867,982
- Issue date Jan 11, 2011
- Emory University
- Bernard Moss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Oncolytic Immunotherapy by Tumor Micro-Environment Remodeling
- Publication number 20250009824
- Publication date Jan 9, 2025
- KaliVir Immunotherapeutics, Inc.
- Stephen Howard THORNE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HUMAN METAPNEUMOVIRUS COMBINATION VACCINE
- Publication number 20240358812
- Publication date Oct 31, 2024
- Valneva SE
- Urban Lundberg
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FIBROBLAST DELIVERY OF TUMOR INHIBITORY AGENTS
- Publication number 20240293468
- Publication date Sep 5, 2024
- FIGENE, LLC
- Pete O'Heeron
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FIBROBLAST DELIVERY OF TUMOR INHIBITORY AGENTS
- Publication number 20240293469
- Publication date Sep 5, 2024
- FIGENE, LLC
- Pete O'Heeron
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination Therapy for Treating Cancer with an Intravenous Adminis...
- Publication number 20240269254
- Publication date Aug 15, 2024
- Bavarian Nordic A/S
- Henning Lauterbach
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOTHERAPEUTIC VACCINE AND ANTIBODY COMBINATION THERAPY
- Publication number 20240024437
- Publication date Jan 25, 2024
- Transgene S.A.
- Philippe Slos
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Oncolytic Immunotherapy by Tumor Micro-Environment Remodeling
- Publication number 20230256041
- Publication date Aug 17, 2023
- KaliVir Immunotherapeutics, Inc.
- Stephen Howard THORNE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
STRAIN DIS-DERIVED RECOMBINANT VACCINIA VIRUS HAVING NOVEL INFLUENZ...
- Publication number 20230174586
- Publication date Jun 8, 2023
- TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE
- Fumihiko YASUI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DELIVERY OF SIALIDASE TO CANCER CELLS, IMMUNE CELLS AND THE TUMOR M...
- Publication number 20230149487
- Publication date May 18, 2023
- Ansun Biopharma, Inc.
- Nancy CHANG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
POXVIRUS-BASED VECTORS PRODUCED BY NATURAL OR SYNTHETIC DNA AND USE...
- Publication number 20230097513
- Publication date Mar 30, 2023
- CITY OF HOPE
- Don J. DIAMOND
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GENETICALLY ENGINEERED ONCOLYTIC VACCINIA VIRUSES AND METHODS OF US...
- Publication number 20220290179
- Publication date Sep 15, 2022
- Astellas Pharma Inc.
- Shinsuke Nakao
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ONCOLYTIC VACCINIA VIRUS
- Publication number 20220275347
- Publication date Sep 1, 2022
- KM Biologics Co., Ltd.
- Toshio MURAKAMI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MODIFIED INTERLEUKIN 12 AND USE THEREOF IN PREPARING DRUGS FOR TREA...
- Publication number 20220213161
- Publication date Jul 7, 2022
- Beijing Bio-Targeting Therapeutics Technology Inc.
- Yaohe Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENGINEERED ONCOLYTIC VIRUSES EXPRESSING PD-L1 INHIBITORS AND USES T...
- Publication number 20220064672
- Publication date Mar 3, 2022
- University of Southern California
- Siyi CHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Combination Therapy for Treating Cancer with a Poxvirus Expressing...
- Publication number 20210205429
- Publication date Jul 8, 2021
- Bavarian Nordic A/S
- SUSAN FOY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FIBROBLAST DELIVERY OF TUMOR INHIBITORY AGENTS
- Publication number 20210128636
- Publication date May 6, 2021
- FIGENE, LLC
- Pete O'Heeron
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NOVEL GENETICALLY ENGINEERED VACCINIA VIRUSES
- Publication number 20200338149
- Publication date Oct 29, 2020
- Astellas Pharma Inc.
- Shinsuke Nakao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Recombinant Modified Vaccinia Virus Ankara (MVA) Respiratory Syncyt...
- Publication number 20200171142
- Publication date Jun 4, 2020
- BAVARIAN NORDIC A/S
- Cédric Cheminay
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ONCOLYTIC VIRUSES AND THERAPEUTIC MOLECULES
- Publication number 20190330655
- Publication date Oct 31, 2019
- TRANSGENE SA
- Philippe ERBS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HLA-A24 AGONIST EPITOPES OF MUC1-C ONCOPROTEIN AND COMPOSITIONS AND...
- Publication number 20190002513
- Publication date Jan 3, 2019
- The USA, as represented by the Secretary, Dept. of Health & Human Services
- Jeffrey Schlom
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR VIRAL EMBOLIZATION
- Publication number 20180303886
- Publication date Oct 25, 2018
- SILLAJEN, INC.
- Tae Ho HWANG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
WHOLE EXPRESSED CELL AS ANTIGEN CARRIER, AND USE THEREOF IN PREPARI...
- Publication number 20180080042
- Publication date Mar 22, 2018
- Formosa Biomedical Inc.
- Shun-Wen KO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
IMMUNOTHERAPEUTIC VACCINE AND ANTIBODY COMBINATION THERAPY
- Publication number 20180028626
- Publication date Feb 1, 2018
- Transgene S.A.
- Philippe Slos
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITION AND USES THEREOF
- Publication number 20180028635
- Publication date Feb 1, 2018
- Oxford University Innovation Limited
- Katharine Alice Collins
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RECOMBINANT MODIFIED VACCINIA VIRUS ANKARA (MVA) RESPIRATORY SYNCYT...
- Publication number 20170326228
- Publication date Nov 16, 2017
- BAVARIAN NORDIC A/S
- Cédric Cheminay
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
VIRUS-BASED EXPRESSION VECTORS AND USES THEREOF
- Publication number 20170298387
- Publication date Oct 19, 2017
- The USA, as represented by the Secretary, Department of Health and Human Serv...
- Bernard MOSS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS AND COMPOSITIONS TO PRODUCE VACCINES AGAINST SMALLPOX IN PL...
- Publication number 20170239345
- Publication date Aug 24, 2017
- PHARMA GREEN LLC
- Maxim Golovkin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MITOGEN-ACTIVATED PROTEIN KINASE-DEPENDENT RECOMBINANT VACCINIA VIR...
- Publication number 20160281066
- Publication date Sep 29, 2016
- NATIONAL UNIVERSITY CORPORATION TOTTORI UNIVERSITY
- Takafumi Nakamura
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Combination Therapy for Treating Cancer with a Poxvirus Expressing...
- Publication number 20160271239
- Publication date Sep 22, 2016
- BAVARIAN NORDIC A/S
- SUSAN FOY
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Immuno-Oncolytic Therapies
- Publication number 20160235793
- Publication date Aug 18, 2016
- University of Pittsburgh of the Commonwealth System of Higher Education
- Stephen Howard Thorne
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Demonstrated in vivo effect

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and...

Recombinant modified vaccinia virus ankara (MVA) equine encephaliti...

Immuno-oncolytic therapies

Modified interleukin 12 and use thereof in preparing drugs for trea...

Modified interleukin 12 and use thereof in preparing drugs for trea...

Use of MVA or MVAΔE3L as immunotherapeutic agents against solid tumors

Immune modulation

HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and...

Recombinant modified vaccinia virus ankara (MVA) respiratory syncyt...

Virus-based expression vectors and uses thereof

Genetically engineered vaccinia viruses

Recombinant modified vaccinia virus Ankara (MVA) equine encephaliti...

Genetically engineered vaccinia viruses

Use of MVA or MVAΔE3L as immunotherapeutic agents against solid tumors

Recombinant modified vaccinia virus ankara (MVA) respiratory syncyt...

Compositions and methods for viral embolization

Nucleic acids encoding HLA-A24 agonist epitopes of MUC1-C oncoprotein

Whole expressed cell as antigen carrier, and use thereof in prepari...

Recombinant modified vaccinia virus Ankara (MVA) Respiratory Syncyt...

HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and...

Composition and uses thereof

Mitogen-activated protein kinase-dependent recombinant vaccinia vir...

Recombinant modified vaccinia virus ankara (MVA) respiratory syncyt...

Treatment and prevention of malaria

Composition comprising a colloidal synthetic bioresorbable vector a...

System for treating and preventing breast cancer

MVA expressing modified HIV envelope, gag, and pol genes

Custom vectors for treating and preventing pancreatic cancer

Modulation of immune responses by the poxviral K4 protein

MVA expressing modified HIV envelope, gag, and pol genes

Patents Applicationslast 30 patents

Oncolytic Immunotherapy by Tumor Micro-Environment Remodeling

HUMAN METAPNEUMOVIRUS COMBINATION VACCINE

FIBROBLAST DELIVERY OF TUMOR INHIBITORY AGENTS

FIBROBLAST DELIVERY OF TUMOR INHIBITORY AGENTS

Combination Therapy for Treating Cancer with an Intravenous Adminis...

IMMUNOTHERAPEUTIC VACCINE AND ANTIBODY COMBINATION THERAPY

Oncolytic Immunotherapy by Tumor Micro-Environment Remodeling

STRAIN DIS-DERIVED RECOMBINANT VACCINIA VIRUS HAVING NOVEL INFLUENZ...

DELIVERY OF SIALIDASE TO CANCER CELLS, IMMUNE CELLS AND THE TUMOR M...

POXVIRUS-BASED VECTORS PRODUCED BY NATURAL OR SYNTHETIC DNA AND USE...

GENETICALLY ENGINEERED ONCOLYTIC VACCINIA VIRUSES AND METHODS OF US...

ONCOLYTIC VACCINIA VIRUS

MODIFIED INTERLEUKIN 12 AND USE THEREOF IN PREPARING DRUGS FOR TREA...

ENGINEERED ONCOLYTIC VIRUSES EXPRESSING PD-L1 INHIBITORS AND USES T...

Combination Therapy for Treating Cancer with a Poxvirus Expressing...

FIBROBLAST DELIVERY OF TUMOR INHIBITORY AGENTS

NOVEL GENETICALLY ENGINEERED VACCINIA VIRUSES

Recombinant Modified Vaccinia Virus Ankara (MVA) Respiratory Syncyt...

ONCOLYTIC VIRUSES AND THERAPEUTIC MOLECULES

HLA-A24 AGONIST EPITOPES OF MUC1-C ONCOPROTEIN AND COMPOSITIONS AND...

COMPOSITIONS AND METHODS FOR VIRAL EMBOLIZATION

WHOLE EXPRESSED CELL AS ANTIGEN CARRIER, AND USE THEREOF IN PREPARI...

IMMUNOTHERAPEUTIC VACCINE AND ANTIBODY COMBINATION THERAPY

COMPOSITION AND USES THEREOF

RECOMBINANT MODIFIED VACCINIA VIRUS ANKARA (MVA) RESPIRATORY SYNCYT...

VIRUS-BASED EXPRESSION VECTORS AND USES THEREOF

METHODS AND COMPOSITIONS TO PRODUCE VACCINES AGAINST SMALLPOX IN PL...

MITOGEN-ACTIVATED PROTEIN KINASE-DEPENDENT RECOMBINANT VACCINIA VIR...

Combination Therapy for Treating Cancer with a Poxvirus Expressing...

Immuno-Oncolytic Therapies